StockData

Vanda Pharmaceuticals Inc. (VNDA) stock

VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.81+0.00 (0.00%)

Close on Nov 17, 2026Market cap $230.39MP/E –Yield –

Vanda Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Vanda Pharmaceuticals's enterprise value was $195.00M on Nov 11, 2026, against $246.73M a year earlier. Over the last 5 years it ranged from -$22.16M to $567.98M, with a median of $178.79M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$195.00M-56.8%
2025Dec 31, 2025$451.20M+152.4%
2024Dec 31, 2024$178.79M+200.0%
2023Dec 29, 2023$59.59M-83.8%
2022Dec 30, 2022$368.79M-21.2%
2021Dec 31, 2021$468.10M+26.5%
2020Dec 31, 2020$370.07M-41.9%
2019Dec 31, 2019$637.41M-43.5%
2018Dec 31, 2018$1.13B+108.2%
2017Dec 29, 2017$542.11M-2.9%
2016Dec 30, 2016$558.11M+119.5%
2015Dec 31, 2015$254.30M-40.8%
2014Dec 31, 2014$429.37M+59.2%
2013Dec 31, 2013$269.72M–
2012Dec 31, 2012-$29.97M–
2011Dec 30, 2011-$27.64M-155.0%
2010Dec 31, 2010$50.27M–

More Vanda Pharmaceuticals figures

See a number that looks wrong?